Stock VTRS VIATRIS INC.
Add to a list

Charts Viatris Inc.

Stocks

VTRS

US92556V1061

Pharmaceuticals

Market Closed - Nasdaq
Other stock markets
 16:00:00 2026-08-07 EDT 		5-day change 1st Jan Change
16.43 USD +0.86% Intraday chart for Viatris Inc. -6.44% +31.97%
08-06 Tranche Update on Viatris Inc.'s Equity Buyback Plan announced on February 28, 2022. CI
08-06 Harrow, Inc. entered into an Asset Purchase Agreement to acquire TYRVAYA® (varenicline solution) nasal spray 0.03 mg from Viatris Inc. for $100 million. CI

Chart: Technical Analysis

Technical analysis trends

Short TermMid-TermLong Term
Trend

Neutral

Bullish

Bullish

Resistance 17.86 17.86 17.56
Spread/Res.-8.01%-8.01%-6.44%
Spread/Supp.+3.46%+6.90%+25.90%
Support 15.88 15.37 13.05

MarketScreener's Technical Analysis Ratings

Short Term Timing
Middle Term Timing
Long Term Timing
RSI
Bollinger Spread
Unusual Volumes
  1. Stock Market
  2. Stocks
  3. VTRS Stock
  4. Charts Viatris Inc.

Select your edition

All financial news and data tailored to specific country editions

NORTH AMERICA

MarketScreener
United-States
MarketScreener Canada
Canada

MIDDLE EAST

MarketScreener Saudi Arabia
Saudi Arabia
MarketScreener UAE Emirates
United Arab Emirates

EUROPE

Zonebourse
France
MarketScreener Deutschland
Deutschland
Zonebourse Suisse
Suisse
MarketScreener Schweiz
Schweiz
MarketScreener Italia
Italia
MarketScreener Österreich
Österreich
MarketScreener België
België
MarketScreener Nederland
Nederland
MarketScreener España
España
MarketScreener Sverige
Sverige
MarketScreener UK
United Kingdom

APAC

MarketScreener Australia
Australia
MarketScreener India
India
MarketScreener Hong Kong
Hong Kong